To further investigate whether the JAK1/STAT3 pathway is required for SNORA28‐driven CRC cell proliferation and radioresistance, Niclosamide, which is a small‐molecule STAT3 inhibitor,[25] was used to treat CRC cells that stably overexpressed SNORA28. This evidence concerns the gene STAT3 and colorectal carcinoma.